Quercetin Alleviates Demyelination to Mitigate Neuropsychiatric Symptoms Through Promoting Microglia M2 Polarization in Mice with Vascular Dementia

Zihu Tan,Guang Yang,Jing Qiu,Wenjing Yan,Yu Liu,Zhengling Ma,Jia Li,Jing Liu,Nan Shan
DOI: https://doi.org/10.21203/rs.3.rs-1030799/v1
2021-11-01
Abstract:Abstract Cerebral hypoperfusion plays a pivotal role in the ictus and development of vascular dementia (VaD) with neuropsychiatric symptoms. To date, few pharmacological interventions for neuropsychiatric symptoms are available in the VaD patients with neuropsychiatric impairments. Here, our results demonstrated that the extent of demyelination was dramatically deteriorated and the thickness of myelin sheath were evidently decreased in the presence of cerebral hypoperfusion, whereas Quercetin possessed the potential of abrogating these effects at least in part, then relieving anxiety and depression-like behavior when mice exposed to bilateral carotid artery stenosis (BCAS)/chronic restraint stress (CRS). The underlying mechanism was that Quercetin facilitated microglia transformation into M2 phenotype, which expedited secretion of anti-inflammatory cytokines (IL-4 and IL-10), and in turn decreased production of pro-inflammatory factors (TNF-α and IL-1β), thereafter enhancing the microglial engulfment ability of myelin fragments in vitro and in vivo. Collectively, the results demonstrated that that Quercetin facilitated microglia transition into M2 phenotype to reduce demyelination in ventral hippocampus (vHIP), thereafter mitigating neuropsychiatric deficits (including anxiety and depression). The present research broadens the therapeutic scope of Quercetin in central nervous system (CNS) disorders with presence of white matter damage and/or the insufficient activation of M2 microglia, particularly for vascular dementia with/without neuropsychiatric symptoms.
What problem does this paper attempt to address?